Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galina I Lepesheva

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Expert Opinion on Drug Discovery|October 2, 2013
Design or screening of drugs for the treatment of Chagas disease: what shows the most promise?Galina I Lepesheva
Biochimica Et Biophysica Acta|September 12, 2006
Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdomsGalina I Lepesheva, Michael R Waterman
Current Topics in Medicinal Chemistry|May 31, 2011
Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasisGalina I Lepesheva, Michael R Waterman
Biochemical and Biophysical Research Communications|September 13, 2005
Sterol 14 alpha-demethylase, an abundant and essential mixed-function oxidaseMichael R Waterman, Galina I Lepesheva
Biochimica Et Biophysica Acta|June 16, 2010
Structural basis for conservation in the CYP51 familyGalina I Lepesheva, Michael R Waterman
Molecular and Cellular Endocrinology|March 18, 2004
CYP51--the omnipotent P450Galina I Lepesheva, Michael R Waterman
Advances in Parasitology|August 9, 2011
Targeting Trypanosoma cruzi sterol 14α-demethylase (CYP51)Galina I Lepesheva, Fernando Villalta, Michael R Waterman
Biochemistry|July 30, 2003
Conservation in the CYP51 family. Role of the B' helix/BC loop and helices F and G in enzymatic functionGalina I Lepesheva, Cornelia Virus, Michael R Waterman
Parasitology|April 13, 2018
CYP51 as drug targets for fungi and protozoan parasites: past, present and futureGalina I Lepesheva, Laura Friggeri, Michael R Waterman
Journal of Lipid Research|August 18, 2004
Fluconazole binding and sterol demethylation in three CYP51 isoforms indicate differences in active site topologyAouatef Bellamine, Galina I Lepesheva, Michael R Waterman
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Expert Opinion on Drug Discovery|October 2, 2013
Design or screening of drugs for the treatment of Chagas disease: what shows the most promise?Galina I Lepesheva
Biochimica Et Biophysica Acta|September 12, 2006
Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdomsGalina I Lepesheva, Michael R Waterman
Current Topics in Medicinal Chemistry|May 31, 2011
Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasisGalina I Lepesheva, Michael R Waterman
Biochemical and Biophysical Research Communications|September 13, 2005
Sterol 14 alpha-demethylase, an abundant and essential mixed-function oxidaseMichael R Waterman, Galina I Lepesheva
Biochimica Et Biophysica Acta|June 16, 2010
Structural basis for conservation in the CYP51 familyGalina I Lepesheva, Michael R Waterman
Molecular and Cellular Endocrinology|March 18, 2004
CYP51--the omnipotent P450Galina I Lepesheva, Michael R Waterman
Advances in Parasitology|August 9, 2011
Targeting Trypanosoma cruzi sterol 14α-demethylase (CYP51)Galina I Lepesheva, Fernando Villalta, Michael R Waterman
Biochemistry|July 30, 2003
Conservation in the CYP51 family. Role of the B' helix/BC loop and helices F and G in enzymatic functionGalina I Lepesheva, Cornelia Virus, Michael R Waterman
Parasitology|April 13, 2018
CYP51 as drug targets for fungi and protozoan parasites: past, present and futureGalina I Lepesheva, Laura Friggeri, Michael R Waterman
Journal of Lipid Research|August 18, 2004
Fluconazole binding and sterol demethylation in three CYP51 isoforms indicate differences in active site topologyAouatef Bellamine, Galina I Lepesheva, Michael R Waterman
Pageof 7